BiotechTube
Torque Bio

Torque Bio

Cambridge, United States· Est.
torquebio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10M

Overview

Torque Bio is a private, preclinical-stage biotech founded in 2018, focusing on RNA and gene therapy. The company is developing a proprietary technology platform aimed at creating differentiated therapeutics, though specific details are not publicly disclosed on its minimal website. As a young, pre-revenue company, its success will depend on advancing its platform, disclosing pipeline candidates, and securing partnership or investment capital to fund development.

RNA & Gene Therapy

Technology Platform

Proprietary RNA and/or gene therapy platform; specific details not publicly disclosed.

Funding History

1
Total raised:$10M
Seed$10M

Opportunities

The company operates in the high-growth RNA and gene therapy market, which has been validated by recent clinical successes.
Its location in Cambridge provides access to capital, talent, and collaboration networks.
A successful platform could address broad unmet medical needs and attract partnership or acquisition interest.

Risk Factors

As a stealth-mode, pre-revenue company, it faces high technical risk regarding its undisclosed platform's viability.
Significant financing risk exists in a tight capital market, and intense competition in the RNA/gene therapy space from larger, more established players poses a major threat.

Competitive Landscape

The RNA and gene therapy field is intensely competitive, featuring large-cap biopharma (e.g., Pfizer, Roche, Novartis), established biotechs (e.g., Alnylam, Ionis, BioNTech), and numerous well-funded private startups. Torque Bio must demonstrate a clear technological advantage to differentiate itself and capture value.

More companies in RNA Therapeutics (non-mRNA) →More companies in United States →